PFBT
BNTX icon

Parkside Financial Bank & Trust’s BioNTech BNTX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$931 Sell
10
-6
-38% -$565 ﹤0.01% 2429
2026
Q1 		$1.42K Hold
16
– – ﹤0.01% 2226
2025
Q4 		$1.52K Buy
16
+2
+14% +$201 ﹤0.01% 2197
2025
Q3 		$1.38K Hold
14
– – ﹤0.01% 2152
2025
Q2 		$1.49K Sell
14
-12
-46% -$1.21K ﹤0.01% 2099
2025
Q1 		$2.37K Buy
+26
New +$2.91K ﹤0.01% 1837

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Parkside Financial Bank & Trust's BNTX Position: Q2 2026 in Review

Parkside Financial Bank & Trust reduced its BioNTech (BNTX) stake by 38% in Q2 2026, selling an estimated $565 and leaving 10 shares worth $931. The position accounts for ﹤0.01% of the portfolio, ranked #2429.

Parkside Financial Bank & Trust first reported a position in BNTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.37K in Q1 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Parkside Financial Bank & Trust held 10 shares of BioNTech worth $931 as of Q2 2026.
  • Parkside Financial Bank & Trust sold 6 BioNTech shares in Q2 2026, an estimated $565.
  • BioNTech made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2429 holding.
  • Parkside Financial Bank & Trust first reported a position in BioNTech in Q1 2025 and has held it in 6 quarters since.
  • Parkside Financial Bank & Trust's BioNTech position peaked at $2.37K in Q1 2025.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.